Here, we demonstrated that therapeutic targeting of HMGCR or FDPS with lovastatin or zoledronate acid effectively suppressed colon cancer spheroids self-renewal in vitro and tumorigenic potential in vivo. This evidence concerns the gene HMGCR and colonic neoplasm.